Pro-abortion attorneys general from 21 states sent a letter to the Department of Health and Human Services and the Food and Drug Administration on Monday, requesting that important safety restrictions on the abortion pill be lifted.
Mifepristone is the first drug of the two-dose abortion pill. It works to block progesterone, which is produced by the mother’s body to sustain the pregnancy. It cuts off blood and nourishment to the growing child. According to the Washington Free Beacon, in order to commit abortions through the abortion pill, mifepristone’s Risk Evaluation and Mitigation Strategy (REMS) requires that abortionists be registered with an FDA safety program as well as the drug manufacturer. They are also required to tell patients about the possible side effects of mifepristone and hand the patient mifepristone at the facility.
The pro-abortion attorneys general, led by California AG Xavier Becerra, want those rules to be waived during the COVID-19 pandemic, calling them “onerous and medically unnecessary.” They want abortionists to be able to prescribe the abortion pill to women using telemedicine so that women don’t travel to abortion businesses during the coronavirus crisis.
Read more at Live Action >>